• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: The pathophysiology of canine atopy: How a better understanding can lead to better treatment

December 19, 2012
Jennifer L. Garcia, DVM, DACVIM

Recent research has redefined the role of IgE and histamine in the pathogenesis of this disease.

Untitled Document

What they did

The authors review the evolution of our current understanding of the pathophysiology of atopic dermatitis (AD) and the role allergens and the immune system play in its manifestation. Recent research has redefined the role of IgE and histamine in the pathogenesis of this disease.

What they found

Advertisement

Historically, AD was described as a type 1 hypersensitivity reaction in the skin mediated by allergen-specific IgE antibodies. Reexposure to the allergen would trigger mast cell degranulation and histamine release, leading to pruritus and inflammation.

It is now recognized that AD can occur even in the absence of allergen-specific IgE and that, conversely, allergen-specific IgE concentrations can be detected in dogs that do not have clinical manifestations of AD. Other factors such as T cell subpopulations, altered mast cell releasability, and defective skin barrier function may also contribute to the pathogenesis of AD.

Histamine as a mediator of pruritus in canine AD has also been challenged in recent studies. Cytokines and leukotrienes are being actively studied as contributors to the inflammatory response in patients with AD. Ultrastructural changes in the skin surface have also been documented in dogs with AD, which may predispose percutaneous allergen exposure. Whether AD is caused by a primary immune defect or the result of a defect in the skin barrier is still a matter of debate according to the review authors.

Take-home message

Despite greater insight into the pathogenesis of AD, complex immune system interactions make definitive diagnosis and treatment challenging. The authors note that exclusion of other diseases such as infections, ectoparasitic infestations, and food allergies will still be required before intradermal and serologic tests are performed. "Serum-based diagnostic or genetic testing that could be used in collaboration with clinical assessments may help veterinarians prescribe the most appropriate treatments for AD patients more quickly," note the authors.

The authors also state that with this new information, it will eventually be possible to develop safer and more effective treatments that target AD at many points in the cycle.

Marsella R, Sousa CA, Gonzales AJ, et al. Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis. J Am Vet Med Assoc 2012;241(2):194-203.

Related Content:

Dermatology
Expert shares pet care tips for springtime
Expert shares pet care tips for springtime
Molecular allergology: what you need to know about the future of allergy testing
Molecular allergology: what you need to know about the future of allergy testing
Topical therapy and immunotherapy can save time and frustration with dermatology cases
Topical therapy and immunotherapy can save time and frustration with dermatology cases

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement